Project Details
| Status | Active |
|---|---|
| Effective start/end date | 3/7/24 → 3/7/27 |
Funding
- aTyr Pharma, Inc. (Prot #ATYR1923-C-005)
Prot #ATYR1923-C-005: Randomized, Double-Blind, Placebo-Controlled Proof-ofConcept Study to Evaluate the Efficacy, Safety and Tolerability of Efzofitimod in Patients With Systemic Sclerosis Related Interstitial Lung Disease
- Bemiss, Brad (PD/PI)
Project: Research project